Stock AnalizHealthcare Realty Trust Inc HR
Real Estate Investment Trusts · data as of November 13, 2026
Healthcare Realty Trust Inc (HR) is a real estate company listed in the US with a market value of about $6.5B. In the twelve months to September 30, 2026 it had revenue of $1.1B and net income of -$45M, a net margin of -4.0%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is shareholder returns (4/5); the weakest is value (1/5).
Key numbers: a price to free cash flow of 14.8, 5-year revenue growth of 19% a year, a 5-year average ROIC of -3%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 44% below the current price.
Score: 1.8 / 5
Checks passed
- P/FCF below 20
- Profit margin improving
- 5-year revenue growth above 8% a year
- Positive free cash flow
- Liabilities below 60% of assets
- Pays a dividend
- 20% to 100% of free cash flow returned to shareholders
- Dividend 3 years in a row
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.3B | $1.3B | $933M | $535M | $500M | $692M | $696M | $614M | $461M |
| Net income | -$45M | -$246M | -$654M | -$278M | $41M | $67M | $72M | $30M | $213M | $64M | $46M |
| Free cash flow | $443M | $457M | $502M | $451M | -$130M | $135M | $395M | $249M | $260M | $243M | $161M |
| EPS (diluted) | $-0.14 | $-0.71 | $-1.81 | $-0.74 | $0.15 | $0.45 | $0.52 | $0.14 | $1.02 | $0.34 | $0.33 |
| Net margin | -4.0% | -20.8% | -51.6% | -20.7% | 4.4% | 12.5% | 14.4% | 4.4% | 30.6% | 10.4% | 10.0% |
| ROIC | — | — | — | — | — | -3.3% | -2.1% | 0.6% | 0.7% | 1.6% | 2.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 12 analysts is $21.42, 11% above the current price; targets range from $18.00 to $24.00; the consensus rating is “Buy”; expected EPS is $-0.13 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Healthcare Realty Trust stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 44% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Healthcare Realty Trust pay a dividend?
Yes. The dividend yield is about 4.98%, and it has paid dividends for 10 years in our data.
Is Healthcare Realty Trust a good stock to buy?
We do not give buy or sell advice. Healthcare Realty Trust scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.